These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. How low should you go? Determining the optimal cutoff for exhaled carbon monoxide to confirm smoking abstinence when using cotinine as reference. Cropsey KL; Trent LR; Clark CB; Stevens EN; Lahti AC; Hendricks PS Nicotine Tob Res; 2014 Oct; 16(10):1348-55. PubMed ID: 24891552 [TBL] [Abstract][Full Text] [Related]
3. Nicotine patch therapy in 101 adolescent smokers: efficacy, withdrawal symptom relief, and carbon monoxide and plasma cotinine levels. Hurt RD; Croghan GA; Beede SD; Wolter TD; Croghan IT; Patten CA Arch Pediatr Adolesc Med; 2000 Jan; 154(1):31-7. PubMed ID: 10632247 [TBL] [Abstract][Full Text] [Related]
4. Comparable sensitivities of urine cotinine and breath carbon monoxide at follow-up time points of three months or more in a smoking cessation trial. Fritz M; Wallner R; Grohs U; Kemmler G; Saria A; Zernig G Pharmacology; 2010; 85(4):234-40. PubMed ID: 20299823 [TBL] [Abstract][Full Text] [Related]
5. Utilizing exhaled carbon monoxide measurement with self-declared smoking cessation: enhancing abstinence effectiveness in Taiwanese outpatients. Chen CC; Chang CH; Tsai YC; Tseng CW; Tu ML; Wang CC; Lin MC; Liu SF Clin Respir J; 2015 Jan; 9(1):7-13. PubMed ID: 24345098 [TBL] [Abstract][Full Text] [Related]
6. Mobile, Remote, and Individual Focused: Comparing Breath Carbon Monoxide Readings and Abstinence Between Smartphone-Enabled and Stand-Alone Monitors. Tuck BM; Karelitz JL; Tomko RL; Dahne J; Cato P; McClure EA Nicotine Tob Res; 2021 Mar; 23(4):741-747. PubMed ID: 33022057 [TBL] [Abstract][Full Text] [Related]
7. Urine cotinine as an index of smoking status in smokers during 96-hr abstinence: comparison between gas chromatography/mass spectrometry and immunoassay test strips. Acosta M; Buchhalter A; Breland A; Hamilton D; Eissenberg T Nicotine Tob Res; 2004 Aug; 6(4):615-20. PubMed ID: 15370157 [TBL] [Abstract][Full Text] [Related]
8. Financial incentives to promote extended smoking abstinence in opioid-maintained patients: a randomized trial. Sigmon SC; Miller ME; Meyer AC; Saulsgiver K; Badger GJ; Heil SH; Higgins ST Addiction; 2016 May; 111(5):903-12. PubMed ID: 26638126 [TBL] [Abstract][Full Text] [Related]
9. Nicotine patch therapy for smoking cessation combined with physician advice and nurse follow-up. One-year outcome and percentage of nicotine replacement. Hurt RD; Dale LC; Fredrickson PA; Caldwell CC; Lee GA; Offord KP; Lauger GG; Marŭsić Z; Neese LW; Lundberg TG JAMA; 1994 Feb; 271(8):595-600. PubMed ID: 8301791 [TBL] [Abstract][Full Text] [Related]
10. Predicting smoking cessation. Who will quit with and without the nicotine patch. Kenford SL; Fiore MC; Jorenby DE; Smith SS; Wetter D; Baker TB JAMA; 1994 Feb; 271(8):589-94. PubMed ID: 8301790 [TBL] [Abstract][Full Text] [Related]
11. Biochemical Validation of Self-Reported Smokeless Tobacco Abstinence among Smokeless Tobacco Users: Results from a Clinical Trial of Varenicline in India. Jain R; Jhanjee S; Jain V; Gupta T; Mittal S; Chauhan P; Raghav R; Goelz P; Schnoll RA J Psychoactive Drugs; 2015; 47(4):331-5. PubMed ID: 26317285 [TBL] [Abstract][Full Text] [Related]
12. Effect on smoking quit rate of telling smokers their health risk appraisal in terms of health age: a randomized control trial. Paek YJ; Lee S; Kim YH; Lee KS; Yim HW; Kim MS; Kim CH; Jeung O Asian Pac J Cancer Prev; 2014; 15(12):4963-8. PubMed ID: 24998572 [TBL] [Abstract][Full Text] [Related]
13. Voucher-based incentives for cigarette smoking reduction in a women's residential treatment program. Robles E; Crone CC; Whiteside-Mansell L; Conners NA; Bokony PA; Worley LL; McMillan DE Nicotine Tob Res; 2005 Feb; 7(1):111-7. PubMed ID: 15804683 [TBL] [Abstract][Full Text] [Related]
14. Two studies of the clinical effectiveness of the nicotine patch with different counseling treatments. Fiore MC; Kenford SL; Jorenby DE; Wetter DW; Smith SS; Baker TB Chest; 1994 Feb; 105(2):524-33. PubMed ID: 8306757 [TBL] [Abstract][Full Text] [Related]
15. A study on urine cotinine for the evaluation of smoking cessation. Takeda N; Jitsunari F; Asakawa F; Suna S; Manabe Y; Goda K Nihon Eiseigaku Zasshi; 1995 Jun; 50(2):637-51. PubMed ID: 7630032 [TBL] [Abstract][Full Text] [Related]
17. Efficacy of varenicline combined with nicotine replacement therapy vs varenicline alone for smoking cessation: a randomized clinical trial. Koegelenberg CF; Noor F; Bateman ED; van Zyl-Smit RN; Bruning A; O'Brien JA; Smith C; Abdool-Gaffar MS; Emanuel S; Esterhuizen TM; Irusen EM JAMA; 2014 Jul; 312(2):155-61. PubMed ID: 25005652 [TBL] [Abstract][Full Text] [Related]
18. Comparison of questionnaire, breath carbon monoxide and urine cotinine in assessing the smoking habits of Type 2 diabetic patients. Ismail AA; Gill GV; Lawton K; Houghton GM; MacFarlane IA Diabet Med; 2000 Feb; 17(2):119-23. PubMed ID: 10746481 [TBL] [Abstract][Full Text] [Related]
19. Error in smoking measures: effects of intervention on relations of cotinine and carbon monoxide to self-reported smoking. The Lung Health Study Research Group. Murray RP; Connett JE; Lauger GG; Voelker HT Am J Public Health; 1993 Sep; 83(9):1251-7. PubMed ID: 8363000 [TBL] [Abstract][Full Text] [Related]
20. A randomized clinical trial to determine the effectiveness of CO-oximetry and anti-smoking brief advice in a cohort of kidney transplant patients who smoke: study protocol for a randomized controlled trial. Pita-Fernández S; Seijo-Bestilleiro R; Pértega-Díaz S; Alonso-Hernández Á; Fernández-Rivera C; Cao-López M; Seoane-Pillado T; López-Calviño B; González-Martín C; Valdés-Cañedo F Trials; 2016 Apr; 17():174. PubMed ID: 27036112 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]